Drainage After Rectal Excision for Rectal Cancer

NCT ID: NCT01269567

Last Updated: 2015-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

494 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

After rectal excision, the rate of anastomotic leak and abscess is higher than after colic surgery. In order to limit and avoid the risk of pelvic sepsis after rectal excision, a prophylactic pelvic drainage is usually used. If current data have confirmed the uselessness of drainage in colic surgery, the question stay in abeyance in rectal surgery. This practice had never been evaluated in patients with rectal excision and low anastomosis (patients with a high risk of pelvic sepsis)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After rectal excision, the rate of anastomotic leak and abscess is higher than after colic surgery. In order to limit and avoid the risk of pelvic sepsis after rectal excision, a prophylactic pelvic drainage is usually used. If current data have confirmed the uselessness of drainage in colic surgery, the question stay in abeyance in rectal surgery. This practice had never been evaluated in patients with rectal excision and low anastomosis (patients with a high risk of pelvic sepsis) The aim of the study is to assess the impact of pelvic drainage vs. non pelvic drainage on risk of pelvic sepsis after rectal excision for cancer with infraperitoneal anastomosis. The principal objective is to compare the rate of pelvic sepsis until 30 days between the 2 groups of patients who had a rectal excision with and without pelvic drainage. It is a randomized clinical trial of superiority, multicentric, without blinding, in 2 parallel groups with ratio (1:1): distribution of the number of patients in the groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer Surgery Randomized Clinical Trial Multicenter Study Pelvic Drainage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Drainage

Rectal excision with aspiration pelvic drainage

Group Type ACTIVE_COMPARATOR

Laying and management of the drain (strictly randomized arm with drainage)

Intervention Type PROCEDURE

At the end of intervention, the surgeon will position an aspiration drain in order to permit a postoperative pelvic drainage. The drain will be positioned forward sacrum, behind anastomosis. The drain will be leaved in place between 3 and 5 days. The criteria of drain ablation are the absence of haemorrhagic liquid and/or un daily debit \< 100ml. Nursing care will be daily with change of bottle for collect pelvic serosity, accounting of quantity of collected liquid and realization of a dried bandage through contact with penetration of the drain.

No drainage

Rectal excision without aspiration pelvic drainage

Group Type EXPERIMENTAL

No pelvic drainage

Intervention Type PROCEDURE

no aspiration drain at the end of intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laying and management of the drain (strictly randomized arm with drainage)

At the end of intervention, the surgeon will position an aspiration drain in order to permit a postoperative pelvic drainage. The drain will be positioned forward sacrum, behind anastomosis. The drain will be leaved in place between 3 and 5 days. The criteria of drain ablation are the absence of haemorrhagic liquid and/or un daily debit \< 100ml. Nursing care will be daily with change of bottle for collect pelvic serosity, accounting of quantity of collected liquid and realization of a dried bandage through contact with penetration of the drain.

Intervention Type PROCEDURE

No pelvic drainage

no aspiration drain at the end of intervention

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Rectal adenocarcinoma, histopathologically proved, with or without neoadjuvant treatment
* Stapler or manual infraperitoneal anastomosis
* With or without stoma
* With bowel preparation
* Open or laparoscopic approach
* Stage T1-T4 Nx Mx
* Age 18 years old or older
* Information of the patient and signature of informed consent
* Affiliation to a regime of social insurance

Exclusion Criteria

* Colonic cancer (\> 15 cm from anal verge)
* Abdominoperineal resection
* Associated resection (prostate, seminal bladder, vagina…)
* Simultaneous liver resection
* Total coloproctectomy
* Emergency
* Infected rectal tumour
* Pregnant women, suitable to be, or current suckling
* Persons deprived of freedom or under guardianship
* Persons under protection of justice
* Impossibility to accept the medical follow-up of the study for geographic , social or psychic reasons.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adélaïde Doussau, Dr

Role: STUDY_CHAIR

University Hospital, Bordeaux

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHRU de Strasbourg

Strasbourg, , France

Site Status

Service de Chirurgie Digestive - Hôpital Purpan - Pavillon Dieulafoy

Toulouse, , France

Site Status

CHU d'AMIENS

Amiens, , France

Site Status

CH de BEAUVAIS

Beauvais, , France

Site Status

Service de Chirurgie Digestive - Hôpital Saint-André - CHU de Bordeaux

Bordeaux, , France

Site Status

Service de Chirurgie Générale et Digestive - Hôpital Beaujon

Clichy, , France

Site Status

Service de Chirurgie Digestive - Hôpital A. Michallon

La Tronche, , France

Site Status

APHP-Kremlin Bicetre

Le Kremlin-Bicêtre, , France

Site Status

Département de Chirurgie Oncologique - Centre Oscar Lambret

Lille, , France

Site Status

CHRU Lille

Lille, , France

Site Status

Centre Hospitalier Lyon Sud

Lyon, , France

Site Status

Département de Chirurgie Oncologique - Institut Paoli Calmette

Marseille, , France

Site Status

Service de Chirurgie Digestive et Viscérale - CHU Timone

Marseille, , France

Site Status

Département de Chirurgie Oncologique - CRLC Val d'Aurelle

Montpellier, , France

Site Status

Service de Chirurgie Digestive - CHU de Nantes - Hôtel Dieu

Nantes, , France

Site Status

Service de Chirurgie Générale et Digestive - Hôpital Saint-Antoine

Paris, , France

Site Status

APHP- Saint Joseph

Paris, , France

Site Status

Service de Chirurgie Digestive - Hôpital des Diaconnesses - La Croix Saint-Simon

Paris, , France

Site Status

CHU Poitiers

Poitiers, , France

Site Status

Service de Chirurgie Viscérale - CHU Pontchaillou

Rennes, , France

Site Status

Service de Chirurgie Digestive - CHU Charles Nicolle

Rouen, , France

Site Status

Service de Chirurgie Digestive et Générale - Brabois

Vandœuvre-lès-Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUBX 2010/24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.